IMBECU   20882
INSTITUTO DE MEDICINA Y BIOLOGIA EXPERIMENTAL DE CUYO
Unidad Ejecutora - UE
congresos y reuniones científicas
Título:
Severe Multisystemic Postdiarrheal Hemolytic Uremic Syndrome
Autor/es:
GARRAMUÑO VALLÉS PATRICIA
Lugar:
Buenos Aires Argentina
Reunión:
Congreso; 7th International Symposium on Shiga Toxinn (Verocytotoxim)-producing Escherichia coli Infections; 2009
Institución organizadora:
Asociación Argentina de Microbiología
Resumen:
<!--
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{mso-style-parent:"";
margin:0cm;
margin-bottom:.0001pt;
mso-pagination:widow-orphan;
font-size:12.0pt;
font-family:"Times New Roman";
mso-fareast-font-family:"Times New Roman";}
a:link, span.MsoHyperlink
{color:blue;
text-decoration:underline;
text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
{color:purple;
text-decoration:underline;
text-underline:single;}
strong
{font-family:"Times New Roman";
mso-bidi-font-family:"Times New Roman";}
pre
{margin:0cm;
margin-bottom:.0001pt;
mso-pagination:widow-orphan;
font-size:10.0pt;
font-family:"Courier New";
mso-fareast-font-family:"Times New Roman";}
span.ti
{mso-style-name:ti;}
@page Section1
{size:612.0pt 792.0pt;
margin:70.85pt 3.0cm 70.85pt 3.0cm;
mso-header-margin:36.0pt;
mso-footer-margin:36.0pt;
mso-paper-source:0;}
div.Section1
{page:Section1;}
-->
Severe Multisystemic Postdiarrheal Hemolytic Uremic Syndrome
Patricia G Vallés. Pathophysiology Department. School of Medicine. University of Cuyo.
Mendoza Argentina
Nonimmune hemolytic anemia, thrombocytopenia,
and acute renal failure are cardinal features of HUS after a prodromal period
of bloody diarrhea caused by Shiga toxin from Escherichia coli (STEC)
Multiorgan failure involving the central nervous system, heart or other systems
or organs may accompany this disease. Although
the clinical features of this D+ HUS are widely known, a clear understanding of
its patho-physiology and treatment remain unclear. The
inflammatory response of host endothelial cells is included in the development
of vascular damage observed in STEC infection, resulting in HUS
(1-2). A breakthrough in HUS pathophysiology was the discovery that endothelial
cells treatment with sublethal doses of Stx2, leads to the upregulation of genes
encoding chemokines and cytokines involved in the chemoattraction and
activation of neutrophils and adhesion molecules mediating binding of
inflammatory cells to the endothelium (3-4) These findings indicate the
important role of Stxs in inducing a multifaceted host inflammatory response. Results from
clinical trials have found that circulating inflammatory mediators, including
ILs, chemokines, soluble adhesion molecules, cytokine receptors, and acute
phase response proteins, are abnormally increased in children with D+ HUS (5,6,7,8).
High circulating neutrophil (PMN) count has been correlated with a poor
prognosis in D+HUS (9) Hypo-responsive PMN with features of previous
degranulation indicating a preceding activation process, have been demonstrated
in D+ HUS children(10). Although these studies do not prove that the elevated
inflammatory mediators have a role in the pathogenesis of this disease, they
indicate a marked host inflammatory response.
The present prospective study was performed so
as to report a group of patients HUS D+ with
serological evidence of Shiga toxin, produced by Ecoli infection,
in the presence of clinical septic shock parameters and multiple organ system failure.
From a total of three hundred seventeen D+ HUS children, we prospectively
studied twenty five D+HUS children (median age 2.5 ± 1.7 years range 1 to 8 years) with clinical hemodynamics
parameters of septic shock and multiple organ system failure. Signs of severe
neurological dysfunction at the time of admission were demonstrated.High
leukocyte count was demonstrated. The twenty five patients with increased Prism
score: 20 ± 2 after admission on Intensive Care Unit, required mechanical
ventilator assistance for 9.7 ± 1.2 days, early inotropic drugs support for
10.2 ±1.7 days and dialysis for 16.3± 4 days, Neurological dysfunction included
generalized tonic-clonic seizures lasted for 4.2 ±1.3 days, n:16. Focal
seizures were present in the remaining patients. Dilated cardiomyopathy was
present in 9 children. Nine children suffered haemorrhagic colitis. Twenty
patients survived. Within one year of the injury, neurological sequelaes, GOS 3
and 4, were present in four patients, chronic renal failure in three patients.
The adverse
clinical outcome at short-term follow up, similar to septic shock, allows us to
suggest an intense inflammatory amplified response after STx exposure in these
patients. Future studies will be required to elucidate the mechanisms involved
in this early severe clinical presentation in D+ HUS patients.
References
1-Proulx F,
Seidman EG, Karpman D. Pathogenesis of Shiga toxin-associated hemolytic uremic
syndrome. Pediatr Res. 2001; 50: 163-171.
2- Westerholt S, Pieper AK, Griebel M, Volk HD, Hartung T, Oberhoffer R. Characterization
of the cytokine immune response in children who have experienced an episode of
typical hemolytic-uremic syndrome. Clin Diagn Lab Immunol. 2003; 10 (6):1090-5.
3-Brigotti M,
Carnicelli D,
Ravanelli E,
Vara AG,
Martinelli C,
Alfieri RR,
Petronini PG,
Sestili P.
Molecular damage and induction of proinflammatory cytokines in human
endothelial cells exposed to Shiga toxin 1, Shiga toxin 2, and alpha-sarcin. Infect Immun. 2007; 75(5):2201-7
4- Zoja C, Angioletti S, Donadelli R, Zanchi C,
Tomasoni S, Binda E, Imberti B, te Loo M, Monnens L, Remuzzi G, Morigi M. Shiga
toxin-2 triggers endothelial leukocytes adhesion and transmigration via NF-B-dependent
up-regulation of IL-8 and MCP-1. Kidney Int.2002; 62:846-856
5- Litalien C, Proulx F, Mariscalco MM, Robitaille P,
Turgeon JP, Orrbine E, Rowe PC, McLaine PN, Seidman E
Circulating
inflammatory cytokine levels in hemolytic uremic syndrome. Pediatr
Nephrol. 1999;13 (9): 840-5.
6- Murata A, Shimazu T, Yamamoto T, Taenaka N, Nagayama K, Honda T, Sugimoto H, Monden M, Matsuura N, Okada S.Profiles of
circulating inflammatory- and antiinflammatory cytokines in patients with
hemolytic uremic syndrome due to E. coli O157infection. Cytokine 1998; 10
: 544-548.
7-Westerholt S, Hartung T, Tollens M, Güstrau A, Oberhoffer M, Karch H, Klare B, Pfeffer K, Emmrich P, Oberhoffer R. Inflammatory
and immunological parameters in children with haemolytic uremic syndrome (HUS)
and gastroenteritis-pathophysiological and diagnostic clues. Cytokine 2000;
12:822-827.
8- Fitzpatrick MM, Shah V, Trompeter RS, Dillon MJ,
Barratt TM.Interleukin-8 and polymorphoneutrophil leucocyte activation in hemolytic
uremic syndrome of childhood. Kidney Int 1992, 42:951956.
9-Fitzpatrick MM, Shah V,Filler G, Dillon MJ, Barratt
TM. Neutrophil activation in the haemolytic uraemic syndrome: free and
complexed elastase in plasma. Pediatric Nephrol 1992; 6:50-53.
10-Fernández GC, Gómez SA, Rubel CJ, Bentancor LV, Barrionuevo P, Alduncín M, Grimoldi I, Exeni R, Isturiz MA, Palermo MS Impaired
neutrophils in children with the typical form of hemolytic uremic syndrome. Pediatr Nephrol. 2005; 20(9):1306-14.